Kun Ho Yoon
Overview
Explore the profile of Kun Ho Yoon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1064
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bae J, Park E, Lee H, Yoon K, Won K, Kim H, et al.
Diabetes Metab J
. 2024 Feb;
48(4):790-801.
PMID: 38310877
Backgruound: This study examines integrating physical and mental healthcare for disadvantaged persons with type 2 diabetes mellitus and mild-to-moderate depression in the community, using a mobile application within a public-private-academic...
2.
Han K, Kim Y, Kim D, Lee B, Chon S, Sohn T, et al.
Diabetes Metab J
. 2023 Feb;
47(6):796-807.
PMID: 36756676
Backgruound: Enavogliflozin is a novel sodium-glucose cotransporter-2 inhibitor currently under clinical development. This study evaluated the efficacy and safety of enavogliflozin as an add-on to metformin in Korean patients with...
3.
Lim Y, Ha J, Yoon K, Baek K, Kang M
Bone
. 2021 Feb;
145:115878.
PMID: 33571697
Background: Bone mineral density (BMD) assessments alone might not be sufficient for assessing fracture risk in the whole population, and decreased balance is an important risk factor for fracture. The...
4.
Jung C, Son J, Kang S, Kim W, Kim H, Kim H, et al.
Diabetes Metab J
. 2021 Jan;
45(1):1-10.
PMID: 33434426
Background: This study aimed to investigate the recent prevalence, management, and comorbidities of diabetes among Korean adults aged ≥30 years by analyzing nationally representative data. Methods: This study used data...
5.
Yoo S, Chang S, Sohn T, Kwon H, Lee J, Moon S, et al.
Diabetes Metab J
. 2020 Nov;
45(6):954-959.
PMID: 33176094
We assessed the glycaemic durability with early combination (EC; vildagliptin+metformin [MET], n=22) versus MET monotherapy (n=17), among newly-diagnosed type 2 diabetes mellitus (T2DM) enrolled (between 2012 and 2014) in the...
6.
Ji L, Chan J, Yu M, Yoon K, Kim S, Choi S, et al.
Diabetes Obes Metab
. 2020 Sep;
23(1):3-17.
PMID: 32991073
Type 2 diabetes (T2D) in the East Asian population is characterized by phenotypes such as low body mass index, an index of β-cell dysfunction, and higher percentage of body fat,...
7.
Choi Y, Yang Y, Hwang B, Lee E, Yoon K, Chang K, et al.
Clin Cardiol
. 2020 Jul;
43(9):1040-1047.
PMID: 32656853
Background: Obstructive coronary artery disease (OCAD) is a significant predictor of adverse clinical events in asymptomatic patients with type 2 diabetes mellitus (T2DM). Hypothesis: We sought to develop an easy-to-use...
8.
Jeong I, Yoon K, Lee M
Diabetes Res Clin Pract
. 2020 Jul;
166:108303.
PMID: 32623038
The coronavirus disease-2019 (COVID-19) has been designated as a highly contagious infectious disease caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) since December 2019, when an outbreak of pneumonia...
9.
Noh J, Chang H, Jeong I, Yoon K
Diabetes Metab J
. 2020 Jul;
44(3):372-381.
PMID: 32613777
Diabetes has been associated with more severe outcomes and higher mortality in coronavirus disease 2019 (COVID-19) patients compare to morbidity and mortality in patients without diabetes. Several mechanisms may play...
10.
Lee J, Kim T, Kim H, Lee S, Cho J, Lee H, et al.
Diabetes Metab J
. 2020 May;
44(4):555-565.
PMID: 32431110
Background: Some patients admitted to hospitals for glycemic control experience hypoglycemia despite regular meals and despite adhering to standard blood glucose control protocols. Different factors can have a negative impact...